Home » EMA: Routine Inspections to Focus On Pharmacovigilance Compliance
EMA: Routine Inspections to Focus On Pharmacovigilance Compliance
The EU’s drugs authority is advising manufacturers that routine inspections will now include a focus on compliance with pharmacovigilance reporting requirements. Serious violators will face the Pharmacovigilance Risk Assessment Committee.
International Pharmaceutical Regulatory Monitor
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May